Revance Therapeutics shares owned by Nuveen Asset Management
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Nuveen Asset Management
from 13F filings
Historical chart of Nuveen Asset Management investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Nuveen Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Nuveen Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $6.9M | 604k | 11.47 |
| 2023-06-30 | $10M | 402k | 25.31 |
| 2023-03-31 | $13M | 402k | 32.21 |
| 2022-12-31 | $9.2M | 501k | 18.46 |
| 2022-09-30 | $17M | 619k | 27.00 |
| 2022-06-30 | $5.0M | 359k | 13.82 |
| 2022-03-31 | $7.1M | 371k | 19.06 |
| 2021-12-31 | $6.1M | 374k | 16.32 |
| 2021-09-30 | $11M | 385k | 27.86 |
| 2021-06-30 | $17M | 561k | 29.64 |
| 2021-03-31 | $13M | 456k | 27.95 |
| 2020-12-31 | $14M | 490k | 28.31 |
| 2020-09-30 | $11M | 426k | 25.14 |
| 2020-06-30 | $9.8M | 401k | 24.42 |
| 2020-03-31 | $5.2M | 351k | 14.80 |
| 2019-12-31 | $5.3M | 327k | 16.23 |
| 2019-09-30 | $4.0M | 307k | 13.00 |
| 2019-06-30 | $2.6M | 203k | 12.97 |